Findings from plasmaMATCH Study – using Guardant360® liquid biopsy
Home » Findings from plasmaMATCH Study – using Guardant360® liquid biopsy

GH AMEA on Social Media Findings from plasmaMATCH Study – using Guardant360® liquid biopsy
Findings from plasmaMATCH Study – using Guardant360® liquid biopsy
Findings from plasmaMATCH Study – using Guardant360® liquid biopsy
GH AMEA

Watch this 2-minute video clip entitled “Findings from the plasmaMATCH study” where the Guardant360 test was used for patients with advanced stage breast cancer. These findings were presented by Dr. Shaheenah Dawood, a distinguished medical oncologist from U.A.E., during our Molecular Tumor Board Webinar on Breast Cancer.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at [email protected] or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

Message us